Skip to Main Content

advocacy

Efforts to improve access to health care, the fight for affordable prescription drugs, the response to the COVID-19 pandemic — all issues of public health policy drawing attention from advocates and advocacy groups. On this page you’ll find stories on the funding of patient advocacy organizations, the efforts to improve patient engagement in research and the need for more patient-centered care.

Latest

First Opinion Miranda Wolpert

A global revolution in funding mental health care is coming

Health Eric Boodman

Sammy Basso, progeria advocate, has died at 28

First Opinion Nancy Brown

Congress can prevent deaths from cardiac arrest if it acts now

First Opinion Jane Martin

Louisiana’s new mifepristone and misoprostol law puts my patients at unnecessary risk

First Opinion Marquisha Johns and Casey Doherty

STAT Plus: Congress must reauthorize the Older Americans Act to keep seniors safe from heat

First Opinion Elizabeth Pfiester

How I fought Big Pharma on insulin prices — and won

Politics Mohana Ravindranath

STAT Plus: Why these health tech leaders are making a risky bet, openly backing Trump or Harris

First Opinion Steffie Woolhandler, David U. Himmelstein, Elizabeth Schrier, and Hope Schwartz

Private equity: health care’s vampire

All Coverage

First Opinion David Weill

Medicine needs fiction, especially now

First Opinion Evelyn Tenenbaum and Jed Adam Gross

Removing barriers to split liver transplants will save lives

advertisement

First Opinion Fred D. Ledley

Give pharmaceutical execs the benefit of doubt — but they need to work for it

First Opinion Staja “Star” Booker

When life mirrors research: What a fall on the ice taught me about being Black and in pain

First Opinion Jo Morrison and Eric Moore

Performance-enhancing drugs or placebos? The myth at the heart of anti-doping

First Opinion Alison Bateman-House and Holly Fernandez Lynch

Trump gave patients a ‘right to try.’ It hasn’t helped them

First Opinion Jason Resendez

Make caregiving a defining issue of the 2024 election

Politics Nicholas Florko and Sarah Owermohle

STAT Plus: Dating app Grindr hires Tom Daschle’s firm to lobby on HIV prevention, IVF

Opinions+ Priya Baraniak

STAT Plus: Cell donors are essential for new therapies. They need to be taken care of

First Opinion Mark N. Simon

Supreme Court’s nondecision jeopardizes emergency abortion care

First Opinion Sarah E. Wakeman

To overcome the overdose crisis, addiction treatment must be integrated into the health care system

Politics Rachel Cohrs Zhang and John Wilkerson

STAT Plus: Q&A: The new CEO of biotech’s top trade group on China, vaccines, and Trump

First Opinion Tracy R. Vitale and Caroline Dorsen

Why aren’t philanthropists stepping up to support nursing education?

First Opinion David Tuller, Mady Hornig, and David Putrino

Functional neurological disorder is not an appropriate diagnosis for people with long Covid

First Opinion Richard A. "Red" Lawhern

Doctors ‘overprescribing’ opioids isn’t the cause of the overdose epidemic — and it never was

First Opinion Peter Staley

EcoHealth Alliance: Covid’s anti-science mob extracting its pound of flesh

First Opinion Lynn Brielmaier

My stalled relay race to get access to ALS drugs in development

First Opinion Podcast Patrick Skerrett

Why is eugenics still alive and well in scientific publishing?

First Opinion Pamela K. Gavin

The rare pediatric disease voucher program creates new treatments. I have new data to prove it

First Opinion Richard G. Frank

Psychiatrists aren’t fulfilling the social contract that subsidized their training

First Opinion Bernie Zipprich

Congress called for an ALS moonshot. The plan for it doesn’t leave Earth